...
首页> 外文期刊>ACS medicinal chemistry letters >Antitubercular Nitroimidazoles Revisited: Synthesis and Activity of the Authentic 3-Nitro Isomer of Pretomanid
【24h】

Antitubercular Nitroimidazoles Revisited: Synthesis and Activity of the Authentic 3-Nitro Isomer of Pretomanid

机译:重新审查抗结核硝基咪唑唑:伪造的伪造3-硝基异构体的合成和活性

获取原文
获取原文并翻译 | 示例
           

摘要

A published study of structural features associated with the aerobic and anaerobic activities of 4- and 5-nitroimidazoles had found that the 3-nitro isomer of pretomanid, 8, displayed interesting potencies, including against nitroreductase mutant Mycobacterium tuberculosis. However, recent nuclear magnetic resonance analyses of two trace byproducts, isolated from early process optimization studies toward a large-scale synthesis of pretomanid, raised structural assignment queries, particularly for 8, stimulating further investigation. Following our discovery that the reported compound was a 6-nitroimidazooxazole derivative, we developed a de novo synthesis of authentic 8 via nitration of the chiral des-nitro imidazooxazine alcohol 26 in trifluoroacetic or acetic anhydride, and verified its identity through an X-ray crystal structure. Unfortunately, 8 displayed no antitubercular activity (MICs > 128 μM), whereas the second byproduct (3′-methyl pretomanid) was eight-fold more potent than pretomanid in the aerobic assay. These findings further clarify target specificities for bicyclic nitroimidazoles, which may become important in the event of any future clinical resistance.]]>
机译:<![cdata [ src ='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/amclct/2017/amclct.2017.8.issue-12/acsmedchemlett.7b00356/20171208/图像/中等/ ml-2017-003562_0005.gif“>一种发表的关于4-和5-硝基咪唑的有氧和厌氧活动的结构特征的研究发现,伪造的3-硝基异构体 8 ,显示有趣的效力,包括对硝化酶突变体结核分枝杆菌。然而,最近核磁共振分析了两种痕量副产物,从早期过程优化研究中分离出普瑞曼的大规模合成,提出了结构分配查询,特别是 8 ,刺激进一步调查。遵循我们发现报道的化合物是6-硝基咪唑恶唑衍生物,我们通过硝化的Chiral des-硝基咪唑嗪醇的硝化来开发了正宗的 8 / b>的合成。在三氟乙酸或乙酸酐中26 / b,并通过X射线晶体结构验证其同一性。遗憾的是, 8 显示无抗结核活动(MICS>128μm),而第二个副产品(3'-甲基紫薇)比需氧测定中的伪托运人八倍八倍。这些发现进一步阐明了双环硝基咪唑的靶特异性,这在未来任何临床抵抗的情况下可能变得重要。]]>

著录项

  • 来源
    《ACS medicinal chemistry letters》 |2017年第12期|共6页
  • 作者单位

    Auckland Cancer Society Research Centre School of Medical Sciences The University of Auckland Private Bag 92019 Auckland 1142 New Zealand;

    Auckland Cancer Society Research Centre School of Medical Sciences The University of Auckland Private Bag 92019 Auckland 1142 New Zealand;

    Auckland Cancer Society Research Centre School of Medical Sciences The University of Auckland Private Bag 92019 Auckland 1142 New Zealand;

    Institute for Tuberculosis Research College of Pharmacy University of Illinois at Chicago 833 South Wood Street Chicago Illinois 60612 United States;

    Institute for Tuberculosis Research College of Pharmacy University of Illinois at Chicago 833 South Wood Street Chicago Illinois 60612 United States;

    Summit CMC Alliance LLC 61 Hawthorne Place Summit New Jersey 07901 United States;

    Global Alliance for TB Drug Development 40 Wall Street New York New York 10005 United States;

    Auckland Cancer Society Research Centre School of Medical Sciences The University of Auckland Private Bag 92019 Auckland 1142 New Zealand;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;化学;
  • 关键词

    drug resistance; nitration; nitroimidazole; pretomanid; silyl migration; Tuberculosis;

    机译:耐药;硝化;硝基咪唑;伪造;甲硅烷基迁移;结核病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号